uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology. (Johan Rönnelid)
Show others and affiliations
2011 (English)In: Annals of the Rheumatic Diseases, ISSN 0003-4967, E-ISSN 1468-2060, Vol. 70, no 6, 1095-1098 p.Article in journal (Refereed) Published
Abstract [en]


The anticyclic citrullinated peptide 2 (anti-CCP2) assay is a generic test for antibodies to citrullinated proteins, among which there is a subset of about 50% with antibodies to citrullinated enolase peptide 1 (CEP-1). The anti-CEP-1 positive subset is strongly associated with the HLA-DRB1 shared epitope and its interaction with smoking.


To investigate whether anti-CEP-1 antibodies may be helpful in predicting outcome.


 Anti-CEP-1 and anti-CCP2 antibodies were measured in two prospective cohorts of patients (Karolinska n=272, Norfolk Arthritis Register (NOAR) n=408) with early rheumatoid arthritis (RA). Outcomes measured were C-reactive protein, erythrocyte sedimentation rate, visual analogue scales for pain and global assessment of disease activity, Health Assessment Questionnaire, physician's assessment, swollen and tender joint counts and radiological progression.


 Anti-CCP2 antibodies were present in 57% and 50%, and anti-CEP-1 in 27% and 24% of the Karolinska and NOAR cohorts, respectively. Importantly, no statistically significant differences in clinical outcomes were demonstrated between the anti-CEP-1-/CCP2+ and the anti-CEP-1+/CCP2+ subsets in either cohort, or in radiological outcomes in the Karolinska cohort.


 Although antibodies to specific citrullinated proteins may have distinct genetic and environmental risk factors, the similarity in clinical phenotype suggests that they share common pathways in the pathogenesis of joint disease in RA.


Place, publisher, year, edition, pages
2011. Vol. 70, no 6, 1095-1098 p.
Keyword [en]
Rheumatoid arthritis, ACPA, prognosis
National Category
Rheumatology and Autoimmunity
Research subject
URN: urn:nbn:se:uu:diva-153605DOI: 10.1136/ard.2010.138909ISI: 000290149900036PubMedID: 21367760OAI: oai:DiVA.org:uu-153605DiVA: diva2:417278

De två sista författarna delar sistaförfattarskapet.

Available from: 2011-05-16 Created: 2011-05-16 Last updated: 2015-02-19Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Mathsson, LindaRönnelid, Johan
By organisation
Clinical Immunology
In the same journal
Annals of the Rheumatic Diseases
Rheumatology and Autoimmunity

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 272 hits
ReferencesLink to record
Permanent link

Direct link